Israeli healthcare fund aMoon II said this week it raised $200 million as it looks to invest in mid to late stage life science companies, according to a Reuters report.
The fund, run by billionaire cybersecurity firm Check Point Software co-founder Marius Nacht, will focus on companies in the digital health, medical tech and biopharma industries in India and other health tech hubs, according to the report.
Initial funding came from both strategic and private investors, with new money expected from private investors who have reportedly showed interest in the fund, according to Reuters. The fund has a target goal of $500 million with a hard cap of $750 million.
The fund’s predecessor, the aMoon I fund, focused mainly on early stage groups and invested in 16 startups, according to the report.
The aMoon II fund is the second this month to approach the $200 million mark. Last week, Norwegian investment manager Sector Gamma reported having raised $197.7 million for its new healthcare fund, according to an SEC filing.
